| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Johnson & Johnson (JNJ) has 23 insiders with recent SEC Form 4 filings, including 3 buys and 8 sells. JNJ is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.04M | $1.03B | - | |
| VP | 114.3K | $29.26M | - | |
| CEO | 79.6K | $20.39M | - | |
| VP | 46.2K | $11.83M | - | |
| VP | 46.1K | $11.79M | -23,054 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2021 | Decker Robert J56 | Controller, CAO | Sale+OE | 5,000 | $163.21 | $816,050.00 | -26.0% | +6.1% | +11.3% | |
| Dec 9, 2020 | Sneed Michael E | EVP, Global Corp Aff &COO | Sale+OE | 54,662 | $152.93 | $8,359,459.66 | -49.4% | - | - | |
| Sep 2, 2020 | Wengel Kathryn E61 | EVP, Chief Gsc Officer | Sale+OE | 16,115 | $153.52 | $2,473,937.94 | -11.4% | - | - | |
| Jul 28, 2020 | McEvoy Ashley | EVP, Ww Chair, Medical Devices | Sell | 29,000 | $147.47 | $4,276,630.00 | -57.2% | - | - | |
| Jun 30, 2020 | Johnson & Johnson59 | 10% Owner | Buy | 725,000 | $17.00 | $12,325,000.00 | +24.6% | - | - | |
| Mar 13, 2020 | Perez William D | Director | Buy | 500 | $127.69 | $63,843.00 | +3.2% | - | - | |
| Feb 21, 2020 | Mongon Thibaut | Exec VP, Ww Chair, Consumer | Sale+OE | 39,224 | $147.96 | $5,803,583.04 | -52.3% | - | - | |
| Jan 30, 2020 | Sneed Michael E | EVP, Global Corp Aff &COO | Sale+OE | 58,128 | $149.39 | $8,683,567.54 | -54.1% | - | - | |
| Dec 13, 2019 | Joly Hubert | Director | Buy | 5,000 | $141.28 | $706,399.00 | New | - | - | |
| Dec 12, 2019 | Wengel Kathryn E61 | EVP, Chief Gsc Officer | Sale+OE | 2,017 | $141.07 | $284,538.19 | -3.9% | - | - |